Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Works matching IS 11750561 AND DT 2022 AND VI 23 AND IP 4
Results: 15
1
2
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 547, doi. 10.1007/s40257-022-00702-2
- By:
- Publication type:
- Article
3
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 427, doi. 10.1007/s40257-022-00701-3
- By:
- Publication type:
- Article
4
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 459, doi. 10.1007/s40257-022-00697-w
- By:
- Publication type:
- Article
5
Meat Allergy: A Ticking Time Bomb.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 515, doi. 10.1007/s40257-022-00696-x
- By:
- Publication type:
- Article
6
Author's Reply to Pestana et al. Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?".
- Published in:
- 2022
- By:
- Publication type:
- Letter
7
Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
8
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 499, doi. 10.1007/s40257-022-00693-0
- By:
- Publication type:
- Article
9
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 449, doi. 10.1007/s40257-022-00692-1
- By:
- Publication type:
- Article
10
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 481, doi. 10.1007/s40257-022-00689-w
- By:
- Publication type:
- Article
11
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 571, doi. 10.1007/s40257-022-00688-x
- By:
- Publication type:
- Article
12
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 561, doi. 10.1007/s40257-022-00687-y
- By:
- Publication type:
- Article
13
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 469, doi. 10.1007/s40257-022-00686-z
- By:
- Publication type:
- Article
14
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 433, doi. 10.1007/s40257-022-00679-y
- By:
- Publication type:
- Article
15
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 523, doi. 10.1007/s40257-022-00678-z
- By:
- Publication type:
- Article